FDA-approved · Cash-pay · Ships to your door
Mounjaro® prescription online
FDA-approved tirzepatide from Eli Lilly, prescribed online by a US-licensed clinician when clinically appropriate. Cash-pay; not billed to insurance.
- FDA-approved tirzepatide for type 2 diabetes
- Once-weekly dual GIP / GLP-1 subcutaneous injection
- Reviewed online and shipped from a US-licensed pharmacy
- Flat cash-pay pricing — no insurance billing
Cash-pay price
$1,349/mo
Cash-pay only; not billed to insurance. Eligibility determined by a US-licensed clinician.
About
What is Mounjaro®?
Mounjaro® is the FDA-approved tirzepatide product from Eli Lilly and Company, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.
Pallas dispenses Mounjaro® through US-licensed pharmacies on a cash-pay basis. Insurance routing is not currently supported. Eligibility is determined by a licensed clinician based on your intake and clinical history.
Pivotal trial · SURPASS program
In the SURPASS clinical program, tirzepatide demonstrated significant HbA1c reductions across a range of T2D populations.
Source: Eli Lilly SURPASS trial program. Outcome reflects the cited trial of the FDA-approved product and the conditions studied. Individual results may differ.
Dosing
Dosing & schedule
Mounjaro® uses a dose-escalation schedule. Your clinician determines the right starting dose and pace of escalation based on your indication and tolerability.
- Weeks 1–42.5 mg once weekly — starting dose (non-therapeutic, for tolerability)
- Weeks 5–85 mg once weekly
- Weeks 9+Increased every 4 weeks as tolerated, up to 15 mg weekly maintenance
How it works
01
Complete your online intake
A short, clinical questionnaire — about 5 minutes. Honest answers help your clinician give the best recommendation.
02
A US-licensed clinician reviews
A licensed clinician in your state reviews your intake and decides whether a prescription is clinically appropriate. They may message you for follow-up if needed.
03
Ships from a US-licensed pharmacy
If approved, your prescription is dispensed by a US-licensed pharmacy and shipped to your door in discreet packaging.
Safety
Important safety information
GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and — based on animal studies — a possible risk of thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications. Always disclose your full medical history to your clinician.
FAQ
Common questions
Mounjaro® is the brand name for FDA-approved tirzepatide manufactured by Eli Lilly for type 2 diabetes. Tirzepatide activates both the GIP and GLP-1 receptors, delivered as a once-weekly subcutaneous injection.
No. Mounjaro® is FDA-approved for type 2 diabetes. Zepbound® (also tirzepatide, also by Eli Lilly) is the FDA-approved tirzepatide product for weight management. A licensed clinician may, in some cases, prescribe Mounjaro® off-label for weight when clinically appropriate.
Mounjaro® is $1,349/month on Pallas, billed flat with no insurance routing. The price covers a 28-day supply shipped directly from a US-licensed pharmacy.
No. Pallas is a cash-pay service. Insurance is not currently billed for any medication on the platform. Pricing is flat and disclosed up front — what you see is what you pay.
Complete a short clinical intake — usually under 5 minutes. A US-licensed clinician reviews your history, decides whether a prescription is clinically appropriate, and (if approved) sends it to a US-licensed pharmacy that ships directly to you in discreet packaging.
Yes. There is no long-term contract. You can pause or cancel your subscription at any time from your patient portal. Refunds are handled on a case-by-case basis per our terms.
Start your visit
